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Background: Data on the impact on clinical outcome of cardiac magnetic resonance imaging (CMR) parameters in patients with ST-elevation 
myocardial infarction (STEMI) are limited due to analysis of single-center cohorts and small study sample sizes. Aim of the current study was to 
investigate the prognostic value of infarct size, microvascular obstruction (MO) and myocardial salvage index (MSI) in comparison to traditional 
outcome markers in a large cohort of STEMI patients derived from multicenter studies.
methods: STEMI patients (n=1217) reperfused by primary percutaneous coronary intervention (PCI) within 12 hours after symptom onset 
underwent CMR at 8 centers in Germany. CMR was performed in median 3 days after the index event (interquartile range [IQR] 2;4). Infarct size 
and MO were measured 15 minutes after gadolinium injection. T2-weighted and contrast-enhanced CMR were used to calculate the MSI. Traditional 
outcome markers including age, gender, diabetes, TIMI-flow pre- and post-PCI, as well as ST-segment resolution and left ventricular ejection fraction 
were assessed in all patients. The primary endpoint was defined as a composite of death, non-fatal myocardial reinfarction and congestive heart 
failure (MACE). Clinical follow-up was conducted in median after 12 months (IQR 11;13).
results: Infarct size, MO and MSI were significantly associated with MACE in univariable Cox regression analysis (all p<0.001). In multivariable Cox 
regression analysis including infarct size, MO and MSI as well as traditional outcome markers such as age, gender, diabetes, TIMI-flow pre- and post-
PCI, ST-segment resolution and left ventricular ejection fraction, MSI was independently associated with the occurrence of MACE (hazard ratio 0.98, 
95%CI 0.97-0.99, p=0.004).
conclusion: In this so far largest reported multi-center cohort of reperfused STEMI patients undergoing CMR, infarct size as well as MO and MSI 
were significantly associated with the occurrence of death, non-fatal myocardial reinfarction and congestive heart failure. Even after adjustment for 
traditional outcome markers, MSI was identified as an independent predictor for adverse clinical outcome after STEMI.
